Electromedical Products International Acquires Pulvinar Neuro

Medtronic Acquires SPR Therapeutics

May 20, 2026

Healthcare Services

Medtronic agreed to acquire SPR Therapeutics for approximately $650 million in cash to add SPR’s FDA-cleared Sprint (SPRINT) temporary peripheral nerve stimulation (PNS) technology to its neuromodulation/pain portfolio. Medtronic later completed the acquisition, integrating the SPRINT PNS System to expand minimally invasive, non-opioid chronic and acute pain treatment options.

Quantum Surgical Acquires NeuWave Medical

February 27, 2026

Medical Devices

Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.

Nihon Kohden Acquires 71.4% Stake in Ad‑Tech from ARCHIMED

November 26, 2024

Medical Devices

Nihon Kohden has acquired a 71.4% stake in NeuroAdvanced Corp., the parent of Ad‑Tech Medical Instrument Corporation, from ARCHIMED’s MED II fund, with ARCHIMED retaining a 28.6% minority stake and entering a joint venture with Nihon Kohden. The deal brings together Nihon Kohden’s EEG and monitoring platform with Ad‑Tech’s intracranial neuroelectrodes to strengthen epilepsy diagnostics and expand Ad‑Tech’s global reach across North America, Europe and Asia.

Anumana Acquires NeuTrace to Build Electrophysiology AI Platform

November 7, 2022

Medical Devices

Anumana, an AI-driven health technology company and portfolio company of nference and Mayo Clinic Platform, has acquired NeuTrace and its EP Data Biome platform along with a pipeline of AI-enabled electrophysiology (EP) applications. nference also obtained rights to the Data Biome platform for non-cardiovascular uses, positioning Anumana to expand its in‑procedure AI capabilities and product development across cardiac electrophysiology.

Boston Scientific Investment Agreement with Exclusive Option to Acquire Farapulse, Inc.

September 21, 2020

Medical Devices

Boston Scientific Corporation signed an investment agreement that includes an exclusive option to acquire Farapulse, Inc., a privately held developer of pulsed field ablation technology for atrial fibrillation and other cardiac arrhythmias. Farapulse’s system uses irreversible electroporation (pulsed electric fields) to ablate heart tissue without thermal energy. The platform is investigational and not available for sale.

Tillery Capital Recapitalizes Electromedical Products International (Alpha‑Stim)

September 1, 2016

Medical Devices

Tillery Capital, a family‑office structured private investment firm, completed a recapitalization of Electromedical Products International, Inc. (EPI), the maker of the Alpha‑Stim medical device, with the transaction closing June 30, 2016. EPI, headquartered in Mineral Wells, Texas, manufactures and sells the Alpha‑Stim device worldwide through independent representatives and distributors and markets to the U.S. Department of Defense and Veterans Affairs.